BBIO - BridgeBio Pharma, Inc.
NEXT EARNINGS:
Apr 27, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$98.23
DETAILS
HIGH:
$157.00
LOW:
$83.00
MEDIAN:
$96.00
CONSENSUS:
$98.23
UPSIDE:
43.80%
Market Cap:
13.16B
Volume:
2,430,036
Avg Volume:
2,675,696
52 Week Range:
28.325-84.94
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.10
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
725
IPO Date:
2019-06-27
EPS (TTM):
-2.88
P/E Ratio:
-20.21
Revenue (TTM):
221.90M
Total Assets:
919.34M
Total Debt:
1.73B
Cash & Equiv:
681.10M
Rev Growth (5Y):
40.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-57.9%
Debt/Equity:
-0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $-1.01 | $-0.75 | -34.3% | $14.5M | $149.1M | -90.3% |
| 2025-10-29 | $-0.95 | $-0.88 | -8.0% | $120.7M | $148.2M | -18.5% |
| 2025-08-05 | $-0.95 | $-0.83 | -14.5% | $110.6M | $108.1M | +2.3% |
| 2025-04-29 | $-0.88 | $-1.00 | +12.0% | $116.6M | $68.4M | +70.5% |
| 2025-02-20 | $-1.31 | $-1.09 | -20.2% | $5.9M | $4.0M | +45.6% |
| 2024-11-12 | $-0.86 | $-1.03 | +16.5% | $2.7M | $67.3M | -95.9% |
| 2024-08-01 | $-1.02 | $-1.09 | +6.4% | $2.2M | $3.6M | -39.3% |
| 2024-05-02 | $-0.05 | $-0.40 | +87.5% | $211.1M | $14.0M | +1404.8% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 221.90M | 9.30M | 77.65M | 69.72M | 8.25M | 40.56M | 0 | 0 |
| Net Income | (535.76M) | (643.20M) | (481.18M) | (562.54M) | (448.72M) | (260.44M) | (130.75M) | (30.57M) |
| EPS | -2.88 | -3.95 | -3.35 | -4.43 | -4.10 | -2.48 | -1.42 | -0.33 |
| Total Assets | 919.34M | 546.38M | 623.04M | 1.01B | 703.59M | 631.68M | 464.94M | 98.04M |
| Total Debt | 1.73B | 1.74B | 1.72B | 1.73B | 495.79M | 91.79M | 54.51M | 143.87M |
| Cash & Equivalents | 681.10M | 375.94M | 376.69M | 393.77M | 356.08M | 363.77M | 436.09M | 92.00M |
| Operating Cash Flow | (520.73M) | (527.72M) | (419.49M) | (497.93M) | (399.71M) | (253.59M) | (136.64M) | (40.49M) |
| Free Cash Flow | (521.66M) | (529.03M) | (425.81M) | (546.18M) | (407.23M) | (258.73M) | (154.82M) | (40.95M) |
| FCF per Share | -2.80 | -3.25 | -2.89 | -3.78 | -3.45 | -2.46 | -1.68 | -0.44 |
| Book Value | (1.47B) | (1.35B) | (1.25B) | (870.41M) | 57.91M | 408.45M | (163.99M) | (58.02M) |
| Cash & ST Investments | 681.10M | 434.88M | 471.92M | 836.66M | 607.09M | 545.99M | 436.09M | 92.00M |
| ROC Equity | N/A | N/A | N/A | N/A | -7.75 | -0.64 | N/A | N/A |